The BioAssay network and its implications to future therapeutic discovery

BMC Bioinformatics

Volumn 12, Issue SUPPL.5, 2011, Pages

  Zhang, Jintao ^a   Lushington, Gerald H ^a   Huan, Jun ^b  

^a UNIVERSITY OF KANSAS   (United States)

^b University of Kansas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC CHEMICALS; BIOLOGICAL DATABASE; BIOLOGICAL NETWORKS; MOLECULAR LIBRARIES; NETWORK BIOLOGY; POTENTIAL DRUG TARGETS; SMALL MOLECULES; TECHNOLOGY DEVELOPMENT;

CHEMICAL ANALYSIS; COMPLEX NETWORKS;

BIOASSAY;

PROTEIN;

ANIMAL; ARTICLE; BIOASSAY; DRUG DEVELOPMENT; DRUG THERAPY; FACTUAL DATABASE; HUMAN; INTERNET; METABOLISM; MOUSE; MOUSE MUTANT;

ANIMALS; BIOLOGICAL ASSAY; DATABASES, FACTUAL; DRUG DISCOVERY; DRUG THERAPY; HUMANS; INTERNET; MICE; MICE, KNOCKOUT; PROTEINS;

EID: 79960741740     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-S5-S1     Document Type: Article

References (26)

1. Adams CP, Brantner VV. Estimating the cost of new drug development: is it really 802 million dollars?. Health Aff (Millwood). 2006, 25(2):420-428.
2. Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M. Drug-Target Network. Nat. Biotechnol 2007, 25(10):1119-1126. 10.1038/nbt1338, 17921997.
3. Cokol M, Iossifov I, Weinreb C, Rzhetsky A. Emergent behavior of growing knowledge about molecular interactions. Nat. Biotechnol. 2005, 23:1243-1247. 10.1038/nbt1005-1243, 16211067.
4. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 2004, 3(8):711-716. 10.1038/nrd1470, 15286737.
5. Kennedy T. Managing the drug discovery/development interface. Drug Discovery Today 1997, 2(10):436-444.
6. Sams-Dodd F. Target-based drug discovery: is something wrong?. Drug Discov. Today 2005, 10(2):139-147. 10.1016/S1359-6446(04)03316-1, 15718163.
7. Austin C, Brady L, Insel T, Collins F. NIH Molecular Libraries Initiative. Science 2004, 306(5699):1138-1139. 10.1126/science.1105511, 15542455.
8. Zerhouni E. The NIH Roadmap. Science 2003, 302(5642):63-72. 10.1126/science.1091867, 14526066.
9. Stelzl U, et al. A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome. Cell 2005, 122(6):957-968. 10.1016/j.cell.2005.08.029, 16169070.
10. Chaurasia G, Iqbal Y, Hanig C, Herzel H, Wanker EE, Futschik ME. UniHI: an entry gate to the human protein interactome. Nucl. Acids Res. 2007, 35:D590-D594. 10.1093/nar/gkl817, 1781159, 17158159.
11. Chaurasia G, Malhotra S, Russ J, Schnoegl S, Hanig C, Wanker EE, Futschik ME. UniHI 4: new tools for query, analysis and visualization of the human protein-protein interactome. Nucl. Acids Res. 2009, 37:D657-660. 10.1093/nar/gkn841, 2686569, 18984619.
12. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucl. Acids Res. 2006, 34:D668-D672. 10.1093/nar/gkj067, 1347430, 16381955.
13. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucl. Acids Res. 2008, 36:D901-D906. 2238889, 18048412.
14. Hamosh A, Scott A, Amberger J, Bocchini C, McKusick V. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucl. Acids Res. 2005, 33:D514-D5177. 539987, 15608251.
15. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL. The human disease network. Proc. Natl. Acad. Sci. 2007, 104(21):8685-8690. 10.1073/pnas.0701361104, 1885563, 17502601.
16. Barabasi AL, Albert R. Emergence of Scaling in Random Networks. Science 1999, 286(5439):509-512. 10.1126/science.286.5439.509, 10521342.
17. Ravasz E, Somera A, Mongru D, Oltvai Z, Barabasi AL. Hierarchical organization of modularity in metabolic networks. Science 2002, 297:1551-1555. 10.1126/science.1073374, 12202830.
18. Eppig JT, Bult CJ, Kadin JA, Richardson JE, Blake JA, . Mouse Genome Database Group The Mouse Genome Database (MGD): from genes to mice-a community resource for mouse biology. Nucl. Acids Res 2005, 33:D471-D475. 10.1093/nar/gki498, 540067, 15608240, Mouse Genome Database Group.
19. Petrotchenko E, Doerflein M, Kakuta Y, Pedersen L, Negishi M. Substrate Gating Confers Steroid Specificity to Estrogen Sulfotransferase. J. Biol. Chem. 1999, 274(42):30019-30022. 10.1074/jbc.274.42.30019, 10514486.
20. Wang F, Zhu Y, Huang Y, McAvoy S, Johnson W, et al. Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis. Oncogene 2005, 24:3875-3885. 10.1038/sj.onc.1208546, 15735666.
21. Neubig R, Siderovski D. Regulators of G-Protein Signalling As New Central Nervous System Drug Targets. Nat. Rev. Drug Discov. 2002, 1:187-197. 10.1038/nrd747, 12120503.
22. Xie G, Palmer P. RGS Proteins: New Players in the Field of Opioid Signaling and Tolerance Mechanisms. Anesth. Analg. 2005, 100:1034-1042. 10.1213/01.ANE.0000147711.51122.4B, 15781518.
23. Hua Y, Vickers T, Baker B, Bennett C, Krainer A. Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol 2007, 5(4):e73. 10.1371/journal.pbio.0050073, 1820610, 17355180.
24. M N, Borlak J. RSK4 and PAK5 Are Novel Candidate Genes in Diabetic Rat Kidney and Brain. Mol. Pharmacol. 2005, 67:604-611.
25. Westwood I, Cheary D, Baxter J, Richards M, van Montfort R, Fry A, Bayliss R. Insights into the Conformational Variability and Regulation of Human Nek2 Kinase. J. Mol. Biol. 2009, 386(2):476-485. 10.1016/j.jmb.2008.12.033, 2741569, 19124027.
26. Morfini G, You Y, Pollema S, Kaminska A, Liu K, et al. Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat. Neurosci. 2009, 12(7):864-871. 10.1038/nn.2346, 2739046, 19525941.